➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
AstraZeneca
Express Scripts
Medtronic
Colorcon

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 9,248,187

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,248,187
Title:Oxadiazole inhibitors of leukotriene production for combination therapy
Abstract: The present invention relates to combination therapy using compound of formula (I): ##STR00001## or pharmaceutically acceptable salts thereof, wherein R.sup.1-R.sup.5 are as defined herein and an additional pharmaceutically active agent. The invention also relates to pharmaceutical compositions comprising these combinations, and methods of using these combinations in the treatment of various diseases and disorders.
Inventor(s): Bylock; Lars Anders (Wiesbaden, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:13/755,351
Patent Claims:see list of patent claims

Details for Patent 9,248,187

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24   Start Trial Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) 2039-02-26 RX search
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 002 2017-04-24   Start Trial Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Colorcon
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.